Search

everythinglearnresearchcommunity

for

Search:↓

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Finasteride effectively treats hidradenitis suppurativa for most patients.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The oral contraceptive improved hair and skin quality in women.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Certain drugs that block specific enzymes can help treat prostate diseases.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.